Combination treatment of pegylated interferon and tenofovir versus tenofovir for people with chronic hepatitis B

This is a protocol for a Cochrane Review (intervention). The objectives are as follows:

To evaluate the benefits and harms of pegylated interferon combined with tenofovir versus tenofovir monotherapy in adults with chronic hepatitis B.

This is a protocol.

Published:

4 August 2023

Authors:

Li H, Wang C, Chai L, Qi X

Was this helpful? Donate.

If you found this evidence helpful, please consider donating to Cochrane. We are a charity that produces accessible evidence to help people make health and care decisions.
Donate
Print
PDF
Citation
Li H, Wang C, Chai L, Qi X. Combination treatment of pegylated interferon and tenofovir versus tenofovir for people with chronic hepatitis B (Protocol). Cochrane Database of Systematic Reviews 2023, Issue 8. Art. No.: CD015730. DOI: 10.1002/14651858.CD015730.